Boron-containing delocalised lipophilic cations for the selective targeting of cancer cells

To limit the incidence of relapse, cancer treatments must not promote the emergence of drug resistance in tumour and cancer stem cells. Under the proviso that a therapeutic amount of boron is selectively delivered to cancer cells, Boron Neutron Capture Therapy (BNCT) may represent one approach that...

Descripción completa

Detalles Bibliográficos
Autores principales: Gianpiero, Calabrese, Anis, Daou, Aikaterini, Rova, Eirini, Tseligka, Ioannis, Vizirianakis S., Dimitrios, Fatouros G., John, Tsibouklis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2016
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072302/
https://www.ncbi.nlm.nih.gov/pubmed/30108691
http://dx.doi.org/10.1039/c6md00383d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072302/
https://www.ncbi.nlm.nih.gov/pubmed/30108691
http://dx.doi.org/10.1039/c6md00383d

Ejemplares similares